# Exploratory Use of Proximal Cryoneurolysis and Distal Botulinum Toxin Type A for Upper-Limb Spasticity: A Case Report with Scoping Review

**Authors:** Di Lorenzo Luigi, De Meo Bruno, Forte Alfonso Maria, Forte Francesco, Palmieri Vincenzo, Pirraglia Nicola, D’Avanzo Carmine

PMC · DOI: 10.3390/toxins18020066 · Toxins · 2026-01-27

## TL;DR

A combination of cryoneurolysis and botulinum toxin injections reduced upper-limb spasticity while preserving hand function in a patient with neurodegenerative disease.

## Contribution

Introduces a dual-modulation strategy combining proximal cryoneurolysis and distal BoNT-A for upper-limb spasticity.

## Key findings

- MAS scores improved from 4 to 1–2 with no adverse events.
- Passive shoulder mobility and pain resolution were achieved without distal weakness.
- Scoping review confirmed consistent improvements in spasticity and range of motion in similar cases.

## Abstract

Background: Upper-limb spasticity involving the shoulder girdle and elbow flexors often impairs functional hand use, and although Botulinum toxin type A (BoNT-A) is a first-line therapy, severe proximal synergies may persist while higher doses risk distal weakness. Methods: We report a case of a 47-year-old woman with neurodegenerative tetraparesis and marked shoulder and elbow flexor spasticity treated with bilateral percutaneous cryoneurolysis of the lateral pectoral, thoracodorsal, and musculocutaneous nerves, followed by distal BoNT-A injections, and we conducted a scoping review following Arksey and O’Malley, Levac, and PRISMA-ScR methods to contextualize the current evidence. Results: At one-month follow-up, the patient showed a reduction in MAS from 4 to 1–2, complete resolution of pain, improved passive shoulder abduction and elevation, preserved distal dexterity, and high satisfaction with no adverse events. The scoping review identified consistent MAS and range-of-motion improvements across multiple case reports and small series involving similar proximal nerve targets. Conclusions: The combined proximal cryoneurolysis–distal BoNT-A approach appears to be a feasible dual-modulation strategy for complex upper-limb spasticity when the preservation of hand function is essential, and the emerging literature supports its further investigation.

## Full-text entities

- **Diseases:** multiple sclerosis (MESH:D009103), hereditary spastic paraplegia-like disorder (MESH:D015419), corticospinal tract dysfunction (MESH:D014570), communication impairments (MESH:D003147), hemophilia A (MESH:D006467), elbow and wrist flexor spasticity (MESH:D014954), adduction (MESH:C562949), arteriovenous malformation (MESH:D001165), neuropathic pain (MESH:D009437), gait difficulty (MESH:D020234), post (MESH:D000094025), shoulder and elbow flexor spasticity (MESH:D000070599), neuroma (MESH:D009463), loss of ambulation (MESH:D051346), contracture (MESH:D003286), upper motor neuron lesions (MESH:D016472), bleeding (MESH:D006470), spastic tetraparesis (MESH:C565722), dysarthria (MESH:D004401), oculomotor abnormalities (MESH:D015840), Post-stroke spasticity (MESH:D020521), finger flexor overactivity (MESH:D053201), weakness (MESH:D018908), injury to (MESH:D014947), neurodegenerative (MESH:D019636), -limb spasticity (MESH:D009128), loss of (MESH:D016388), cerebral palsy (MESH:D002547), upper-limb spasticity (MESH:D038062), Pain (MESH:D010146)
- **Chemicals:** CO2 (MESH:D002245), baclofen (MESH:D001418)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12944957/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12944957/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC12944957/full.md

---
Source: https://tomesphere.com/paper/PMC12944957